Pappas DA, O'Brien J, Guo L, Shan Y, et al. Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA Registry. Arthritis Res Ther 2023;25:166.
PMID: 37689684